Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Here’s Why

Eurofins Scient (OTCMKTS:ERFSFGet Free Report)’s share price gapped up before the market opened on Friday . The stock had previously closed at $69.19, but opened at $73.88. Eurofins Scient shares last traded at $72.34, with a volume of 635 shares.

Analysts Set New Price Targets

A number of equities analysts have commented on ERFSF shares. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. One research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold”.

View Our Latest Report on ERFSF

Eurofins Scient Price Performance

The stock has a fifty day moving average of $79.53 and a 200 day moving average of $74.63. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Featured Stories

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.